Carbonic anhydrase inhibitor
Carbonic Anhydrase Inhibitors[edit]
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of the enzyme carbonic anhydrase. This enzyme is crucial in the regulation of pH and fluid balance in various tissues, including the kidney, eye, and central nervous system.
Mechanism of Action[edit]
Carbonic anhydrase inhibitors work by inhibiting the enzyme carbonic anhydrase, which catalyzes the reversible reaction of carbon dioxide and water to form carbonic acid. By inhibiting this enzyme, these drugs reduce the reabsorption of bicarbonate in the proximal tubule of the nephron, leading to increased excretion of bicarbonate, sodium, and water, and thus diuresis.
Clinical Uses[edit]
Carbonic anhydrase inhibitors are used in the treatment of several conditions:
- Glaucoma: By reducing the production of aqueous humor, these inhibitors lower intraocular pressure.
- Altitude sickness: They help in acclimatization by inducing metabolic acidosis, which stimulates ventilation.
- Epilepsy: Some inhibitors have anticonvulsant properties.
- Edema: They are used as diuretics in certain cases of fluid retention.
Common Carbonic Anhydrase Inhibitors[edit]
The most commonly used carbonic anhydrase inhibitor is acetazolamide, which is used for the treatment of glaucoma, altitude sickness, and certain types of seizures. Other examples include dorzolamide and brinzolamide, which are primarily used in the treatment of glaucoma.
Side Effects[edit]
The use of carbonic anhydrase inhibitors can lead to several side effects, including:
- Metabolic acidosis: Due to increased bicarbonate excretion.
- Electrolyte imbalance: Such as hypokalemia.
- Renal stones: Due to increased urinary pH.
- Paresthesia: Tingling sensation in the extremities.
